Table 1

Baseline characteristics in adult patients with Eisenmenger syndrome according to survival

Variables Survivors (n=56) Non-survivors (n=38) p Value
Demographics
 Age (years)37 (2)37 (2)0.9615
 Sex, male/female (n)17/3917/210.1120
 BMI (kg/m2)18.1 (0.3)18.4 (0.6)0.6202
Primary defect (n)
 ASD29190.9642
 VSD16 70.3077
 PDA 8 60.7609
 Other 3 60.0816
NYHA functional class (n)
 II35 70.0001
 III21250.0061
 IV 0 60.0017
Laboratory findings
 Packed cell volume (%)46 (1)49 (2)0.2624
 Mean corpuscular volume (fl)91.4 (0.8)89.0 (1.2)0.1256
 Serum creatinine (μmol/l)69.8 (2.7)82.2 (3.5)0.0081
 Serum total cholesterol (mmol/l) 4.20 (0.13) 4.40 (0.16)0.3155
 Triglycerides (mmol/l) 1.04 (0.07) 0.96 (0.06)0.7183
 Fasting blood glucose (mmol/l) 4.6 (0.1) 4.4 (0.1)0.0724
 Serum uric acid (mg/dl) 5.9 (0.2) 8.7 (0.4)<0.0001
Haemodynamic variables
 mSAP (mm Hg)84 (2)82 (3)0.1915
 mPAP (mm Hg)60 (3)69 (4)0.0396
 CI (l/min/m2) 2.9 (0.1) 2.4 (0.1)0.0059
 TPRI (Wood units/m2)23 (1)31 (2)0.0009
 RAP (mm Hg) 3 (1) 5 (1)0.0165
 PCWP (mm Hg) 8 (1) 6 (2)0.3911
Gas exchange (%)
 Arterial oxygen saturation87 (1)83 (1)0.0105
 Mixed venous oxygen saturation65 (1)60 (1)0.0024
Treatment/procedures (n)
 Diuretics13200.0019
 Digitalis26250.0962
 Vasodilators 7 40.8285
 Anticoagulant agents 7 70.3771
 Venesections 2 80.0054
  • Values are mean (SEM) except for numerical data.

  • ASD, atrial septal defect; BMI, body mass index; CI, cardiac index; mPAP, mean pulmonary arterial pressure; mSAP, mean systemic arterial pressure; NYHA, New York Heart Association; PCWP, pulmonary capillary wedge pressure; PDA, persistent arterial duct; RAP, right atrial pressure; TPRI, total pulmonary resistance index; VSD, ventricular septal defect.